gefitinib

Sandoz launches oncology generic gefitinib in 13 EU countries
Pharmaceutical Business Review
Wed, 07/3/19 - 09:57 am
Sandoz
Novartis
generics
gefitinib
metastatic non-small cell lung cancer
Aveo Oncology reports results of exploratory Phase 2 study of ficlatuzumab
Yahoo/Fly on the Wall
Mon, 10/1/12 - 10:41 am
Aveo Oncology
ficlatuzumab
gefitinib
non-small cell lung cancer